Kamada Ltd. Share Price TEL AVIV STOCK EXCHANGE
Stocks
KMDA
IL0010941198
Pharmaceuticals
| Market Cap | 1.32B 444M 383M 360M 328M 617M 42.43B 625M 4.22B 1.65B 21.26B 1.67B 1.63B 70.76B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 1.32B 444M 383M 360M 328M 617M 42.43B 625M 4.22B 1.65B 21.26B 1.67B 1.63B 70.76B | EV / Sales 2026 * |
2.17x | EV / Sales 2027 * | 1.95x |
| Free-Float |
54.51% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Kamada Ltd.
| 1 day | +3.07% |
| Manager | Title | Age | Since |
|---|---|---|---|
Amir London
CEO | Chief Executive Officer | 58 | 30/06/2015 |
Chaime Orlev
DFI | Director of Finance/CFO | 56 | 30/12/2017 |
Eran Nir
COO | Chief Operating Officer | 54 | 31/10/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
David Tsur
BRD | Director/Board Member | 75 | 12/12/1990 |
Leon Recanati
CHM | Chairman | 77 | 06/03/2013 |
| Chairman | 55 | 11/08/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.07% | +4.32% | - | - | 423M | |
| +0.30% | +2.75% | +38.86% | +1.08% | 80.23B | |
| -1.02% | -0.51% | -2.54% | +28.91% | 50.64B | |
| +1.46% | -3.45% | +11.90% | +164.29% | 46.87B | |
| -1.39% | +1.82% | -50.22% | -50.44% | 46.34B | |
| -0.32% | +0.58% | +50.90% | -21.15% | 31B | |
| +1.80% | +8.94% | +130.05% | -34.84% | 25.28B | |
| +2.78% | +2.44% | +42.08% | +90.79% | 24.36B | |
| +1.65% | +0.53% | -2.21% | +190.26% | 20.81B | |
| +3.95% | +1.02% | +67.20% | +117.59% | 16.08B | |
| Average | +1.07% | +0.35% | +31.78% | +54.05% | 37.96B | |
| Weighted average by Cap. | +0.41% | +0.53% | +23.84% | +39.34% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 608M 204M 177M 166M 151M 284M 19.54B 288M 1.94B 761M 9.79B 767M 751M 32.59B | 676M 227M 196M 184M 168M 316M 21.73B 320M 2.16B 846M 10.89B 853M 835M 36.24B |
| Net income | 85.01M 28.61M 24.71M 23.19M 21.14M 39.74M 2.73B 40.27M 272M 106M 1.37B 107M 105M 4.56B | 104M 35.14M 30.35M 28.5M 25.98M 48.82M 3.36B 49.47M 334M 131M 1.68B 132M 129M 5.6B |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
